IQVIA Expands Collaboration with Veeva Clinical Operations Applications Integration

Expanding Horizons in Clinical Research: The IQVIA and Veeva Collaboration

In a significant move towards enhancing clinical trial efficiencies, IQVIA and Veeva Systems have announced an expansion of their partnership. By selecting Veeva applications, including CTMS (Clinical Trial Management System), eTMF (electronic Trial Master File), Study Startup, and Site Connect, both companies aim to streamline clinical operations across IQVIA's clinical development studies. This expansion is set to bolster the previously established collaboration on EDC (Electronic Data Capture), thereby paving the way for integrating advanced technological solutions into clinical research workflows.

Enhancing Clinical Trial Efficiency
The collaboration between IQVIA and Veeva reflects a shared commitment to improving the speed and efficiency of clinical trials. With the integration of Veeva’s industry-leading applications, both companies aspire to facilitate a research environment that prioritizes the needs and experiences of clinical trial sites. This integration aims to empower clinical teams to make informed decisions more swiftly, ultimately accelerating the delivery of life-changing treatments to patients.

Richard Staub, President of Research and Development Solutions at IQVIA, emphasized the benefits of this collaboration by stating, "By combining the strengths of our companies, we provide clinical teams with a more connected way of working, supported by a seamless integration of our respective technologies." This innovative approach not only enhances operational efficiencies but also allows customers the flexibility to select the EDC, RTSM (Randomized Trials Supply Management), and eCOA (electronic Clinical Outcome Assessments) technologies that best meet their unique needs.

A Bright Future for Clinical Innovation
This expansion is particularly exciting given the nature of the healthcare landscape, which continuously evolves alongside technological advancements. Peter Gassner, Founder and CEO of Veeva, commented positively on the partnership’s growth, stating, "We are committed to providing a smooth integration of products and services for the benefit of our clients and enhancing patients' access to innovations."
The recent developments will be highlighted further at the Veeva R&D and Quality Summit, scheduled for October 20-21 in Boston, where industry experts will explore these advancements in detail.

IQVIA's Leadership in Healthcare Research
IQVIA stands out as a global leader in pharmaceutical and healthcare research. Providing critical insights and data analytics, IQVIA equips stakeholders in the life sciences and healthcare sectors with tools that lead to better decision-making. The company prides itself on leveraging Connected Intelligence™, which embraces high-quality health data, advanced analytics, and cutting-edge technology to drive improvements in patient outcomes.

Specializing in protecting patient privacy, IQVIA employs robust technologies and security measures to safeguard individual information while conducting extensive analysis that helps healthcare professionals identify disease patterns and correlate treatments effectively. With a workforce of approximately 94,000 employees across over 100 countries, IQVIA’s commitment to excellence is evident. They strive to ensure that innovative medical treatments reach the patients who need them most.

Veeva's Role in the Life Sciences Sector
On the other hand, Veeva Systems provides a specialized cloud environment aimed at life sciences companies. Offering applications, services, and data management, Veeva has built a reputation for delivering outstanding solutions that cater to the needs of a diverse clientele—ranging from established pharmaceutical giants to emerging biotech firms. As a public benefit corporation, Veeva focuses on a balanced approach to meet the interests of various stakeholders, reinforcing their commitment to industry innovation and client success.

Conclusion
The strengthened partnership between IQVIA and Veeva epitomizes the merging of technology and healthcare research, driving progress toward faster, more efficient clinical trials. As patients and stakeholders alike eagerly anticipate quicker access to innovative therapies, this collaboration is set to play a crucial role in accelerating healthcare advancements. For more detailed insights into this alliance and its implications for clinical research, visit IQVIA and Veeva.